Tag Archives: pipeline

Drug Pipelines in Canada: Is There a Buyer for Future Innovation?

By Clark Herman | Published: April 15, 2013
Last week, Canada’s National Prescription Drug Utilization Information System (NPDUIS), a federal-provincial fact-finding panel that works closely with the Patented Medicines Prices Review Board (PMPRB), issued its fourth New Drug Pipeline Monitor (NDPM) looking at drugs currently under development that may have an impact on future drug expenditures. The report is another example of how [...]
Posted in Global, IP, Market Access, Orphan Drugs, R&D, Regulatory, healthcare, pricing | Also tagged , , , , | Leave a comment

Will "Robust Pipeline" Yield More New Drugs?

By Jill Wechsler | Published: January 21, 2013
Biopharmaceutical companies are touting their huge investment in R&D, which has filled the drug pipeline with more potential first-in-class medicines, including orphan drugs, personalized medicines and new therapies based on novel scientific strategies. A report by the Analysis Group for the Pharmaceutical Research and Manufacturers of America (PhRMA) documents more than 5,000 new medicines in [...]
Posted in Biotech, FDA, R&D, Regulatory, leadership | Also tagged , , , , , | Leave a comment

Pipeline Report Preview

By Reid Paul | Published: November 14, 2012
Posted in Advertising, Biotech, Europe, FDA, Gene therapy, Global, IP, R&D, Regulatory, Strategy, Video | Also tagged , , , , , , , , | Leave a comment

Public Interest in Private Science: New Pathways to Measuring R&D Success

By William Looney | Published: August 8, 2012
Today’s big product story — the apparent end to a decade-long drought in the drug development pipeline — is the prep stage for tomorrow’s big policy question:  are industry R&D priorities in synch with the changing burden of disease?
Posted in FDA, R&D | Also tagged , , | Leave a comment

Witty Touts GSK Pipeline in 4th Quarter Review

By Reid Paul | Published: February 10, 2012
brightcove.createExperiences();
Posted in Emerging Markets, Europe, Global, News, R&D, Strategy | Also tagged , , , , , | Leave a comment